Fig. 11From: Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor designPeptide 5 binding mode with catalytic domain of various proteins (Red = S1, Blue = S2, Green = S3 and Cyan = S1′)Back to article page